98 related articles for article (PubMed ID: 11502568)
21. Cystic fibrosis transmembrane conductance regulator activation by cAMP-independent mechanisms.
He Z; Raman S; Guo Y; Reenstra WW
Am J Physiol; 1998 Oct; 275(4):C958-66. PubMed ID: 9755049
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the trafficking pathway of cystic fibrosis transmembrane conductance regulator in baby hamster kidney cells.
Okiyoneda T; Harada K; Yamahira K; Wada I; Hashimoto Y; Ueno K; Suico MA; Shuto T; Kai H
J Pharmacol Sci; 2004 Aug; 95(4):471-5. PubMed ID: 15286432
[TBL] [Abstract][Full Text] [Related]
23. SERCA pump inhibitors do not correct biosynthetic arrest of deltaF508 CFTR in cystic fibrosis.
Grubb BR; Gabriel SE; Mengos A; Gentzsch M; Randell SH; Van Heeckeren AM; Knowles MR; Drumm ML; Riordan JR; Boucher RC
Am J Respir Cell Mol Biol; 2006 Mar; 34(3):355-63. PubMed ID: 16284361
[TBL] [Abstract][Full Text] [Related]
24. Cystic fibrosis transmembrane conductance regulator-dependent regulation of epithelial inducible nitric oxide synthase expression.
Steagall WK; Elmer HL; Brady KG; Kelley TJ
Am J Respir Cell Mol Biol; 2000 Jan; 22(1):45-50. PubMed ID: 10615064
[TBL] [Abstract][Full Text] [Related]
25. Determinants of the pH of the Golgi complex.
Schapiro FB; Grinstein S
J Biol Chem; 2000 Jul; 275(28):21025-32. PubMed ID: 10748071
[TBL] [Abstract][Full Text] [Related]
26. Organelle redox of CF and CFTR-corrected airway epithelia.
Schwarzer C; Illek B; Suh JH; Remington SJ; Fischer H; Machen TE
Free Radic Biol Med; 2007 Jul; 43(2):300-16. PubMed ID: 17603939
[TBL] [Abstract][Full Text] [Related]
27. No evidence for direct activation of the cystic fibrosis transmembrane conductance regulator by 8-cyclopentyl-1,3-dipropylxanthine.
Kunzelmann K; Briel M; Schreiber R; Ricken S; Nitschke R; Greger R
Cell Physiol Biochem; 1998; 8(4):185-93. PubMed ID: 9694345
[TBL] [Abstract][Full Text] [Related]
28. Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.
Kreda SM; Mall M; Mengos A; Rochelle L; Yankaskas J; Riordan JR; Boucher RC
Mol Biol Cell; 2005 May; 16(5):2154-67. PubMed ID: 15716351
[TBL] [Abstract][Full Text] [Related]
29. In vivo activation of CFTR-dependent chloride transport in murine airway epithelium by CNP.
Kelley TJ; Cotton CU; Drumm ML
Am J Physiol; 1997 Nov; 273(5):L1065-72. PubMed ID: 9374736
[TBL] [Abstract][Full Text] [Related]
30. Reconstitution of brefeldin A-induced golgi tubulation and fusion with the endoplasmic reticulum in semi-intact chinese hamster ovary cells.
Kano F; Sako Y; Tagaya M; Yanagida T; Murata M
Mol Biol Cell; 2000 Sep; 11(9):3073-87. PubMed ID: 10982401
[TBL] [Abstract][Full Text] [Related]
31. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, -223, and -494 is altered in ΔF508 cystic fibrosis airway epithelium.
Oglesby IK; Chotirmall SH; McElvaney NG; Greene CM
J Immunol; 2013 Apr; 190(7):3354-62. PubMed ID: 23436935
[TBL] [Abstract][Full Text] [Related]
32. A novel fluorescent sensor for measurement of CFTR function by flow cytometry.
Vijftigschild LA; van der Ent CK; Beekman JM
Cytometry A; 2013 Jun; 83(6):576-84. PubMed ID: 23463616
[TBL] [Abstract][Full Text] [Related]
33. CFTR modulates programmed cell death by decreasing intracellular pH in Chinese hamster lung fibroblasts.
Barrière H; Poujeol C; Tauc M; Blasi JM; Counillon L; Poujeol P
Am J Physiol Cell Physiol; 2001 Sep; 281(3):C810-24. PubMed ID: 11502558
[TBL] [Abstract][Full Text] [Related]
34. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of volume-regulated anion channels by expression of the cystic fibrosis transmembrane conductance regulator.
Vennekens R; Trouet D; Vankeerberghen A; Voets T; Cuppens H; Eggermont J; Cassiman JJ; Droogmans G; Nilius B
J Physiol; 1999 Feb; 515 ( Pt 1)(Pt 1):75-85. PubMed ID: 9925879
[TBL] [Abstract][Full Text] [Related]
36. Localisation of wild-type and DeltaF508-CFTR in nasal epithelial cells.
Dormer RL; McNeilly CM; Morris MR; Pereira MM; Doull IJ; Becq F; Mettey Y; Vierfond JM; McPherson MA
Pflugers Arch; 2001; 443 Suppl 1():S117-20. PubMed ID: 11845316
[TBL] [Abstract][Full Text] [Related]
37. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
Andersson C; Dragomir A; Hjelte L; Roomans GM
Clin Sci (Lond); 2002 Oct; 103(4):417-24. PubMed ID: 12241542
[TBL] [Abstract][Full Text] [Related]
38. Molecular basis for defective glycosylation and Pseudomonas pathogenesis in cystic fibrosis lung.
Poschet JF; Boucher JC; Tatterson L; Skidmore J; Van Dyke RW; Deretic V
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13972-7. PubMed ID: 11717455
[TBL] [Abstract][Full Text] [Related]
39. 5'-adenosine monophosphate mediated cooling treatment enhances ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) stability in vivo.
Zhang Y; O'Brien WG; Zhao Z; Lee CC
J Biomed Sci; 2015 Sep; 22(1):72. PubMed ID: 26335336
[TBL] [Abstract][Full Text] [Related]
40. Selective activation of cystic fibrosis transmembrane conductance regulator Cl- and HCO3- conductances.
Reddy MM; Quinton PM
JOP; 2001 Jul; 2(4 Suppl):212-8. PubMed ID: 11875262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
